|
mitomiRs | Specimen | Expression | Clinical relevance | PMID | Reference |
|
miR-4488 | Serum EVs | ↓ | Low expression in TNBC patients | 33067576 | Zheng et al., 2020 [74] |
miR-21 | Serum | ↓ | Decreased level in BC patients after metformin treatment | 28698800 | Pulito et al., 2017 [48] |
miR-34a | Serum Tissue | ↓ | Low expression predicts poor OS of TNBC patients | 31616515 31897330 | Li et al., 2019 [47] Kim et al., 2019 [77] |
miR-29a | Tissue | ↓ | Low expression predicts poor OS of BC patients | 33223849 | Wang et al., 2020 [28] |
miR-1 | Tissue | ↓ | Low expression in BC patients | 31765945 | Zhang et al., 2019 [71] |
miR-324 | Tissue | ↓ | Low expression correlated with large tumor size and advanced TNM stage (III-IV) of BC patients | 31751910 | Zhang et al., 2019 [52] |
miR-342 | Tissue | ↓ | Low expression predicts poor OS of TNBC patients | 30115973 | Romero-Cordoba et al., 2018 [34] |
miR-128 | Tissue | ↓ | Low expression predicts poor OS and DFS of TNBC patients | 29116653 | Xiao et al., 2018 [33] |
miR-125b | Tissue | ↓ | Low expression in BC tissue and TNBC cell line | 29434858 | Hu et al., 2018 |
miR-4485 | Tissue | ↓ | Low expression in BC patients | 28220193 | Sripada et al., 2017 [44] |
miR-663 | Tissue | ↓ | Low expression predicts poor OS of BC patients | 29066618 | Carden et al., 2017 [45] |
miR-195 | Tissue | ↓ | Low expression in TNBC patients | 29183284 | Qattan et al., 2017 [79] |
miR-148a, miR-152 | Tissue | ↓ | Low expression in TNBC tissue compared to adjacent normal tissue | 25703326 | Xu et al., 2015 [46] |
miR-101 | Tissue | ↓ | Low expression associated with advanced TNM stage (III-IV) and lymph node infiltration of TNBC patients | 26036638 | Liu et al., 2015 [55] |
miR-195 | Plasma | ↑ | High expression in TNBC patients | 29183284 | Qattan et al., 2017 [79] |
miR-210 | Plasma | ↑ | High expression in TNBC patients | 29183284 | Qattan et al., 2017 [79] |
miR-16 | Plasma | ↑ | High expression in TNBC patients | 29183284 | Qattan et al., 2017 [79] |
miR-221 | Serum Tissue | ↑ | High expression in serum and tumor tissue of BC patients | 26503209 | Ye et al., 2016 [80] |
miR-27a | Serum | ↑ | High expression in BC patients and in TNBC cell line | 26662313 | Zhou et al., 2016 [81] |
miR-155 | Tissue | ↑ | High expression in tumor tissue indicates elevated glucose uptake of TNBC patients | 29527004 | Kim et al., 2018 [32] |
miR-210 | Tissue | ↑ | High expression in TNBC patients | 29183284 | Qattan et al., 2017 [79] |
miR-16 | Tissue | ↑ | High expression in TNBC patients | 29183284 | Qattan et al., 2017 [79] |
miR-373 | Tissue | ↑ | High expression predicts lymph node metastasis of BC patients | 26196741 | Chen et al., 2015 [53] |
|